BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 8, 2009
View Archived Issues
Further results from ongoing phase I study of AC-220 show benefit in AML patients
Read More
AFP-464 synergistic with vorinostat in breast cancer cells
Read More
I-PRESERVE finds no benefit of irbesartan in heart failure with preserved ejection fraction
Read More
GlaxoSmithKline reports on discovery of EP1 receptor antagonist for inflammatory pain
Read More
Chalcone derivative blocks Abeta impairment of PKA/CREB signaling
Read More
Endo to acquire Indevus
Read More
EMEA accepts Cerepro Marketing Authorization Application for review
Read More
FDA lifts hold on Advaxis' phase II cervical intraepithelial neoplasia trial
Read More
Chimerix completes phase I and initiates phase II multidose trial for CMX-001
Read More
Genta summarizes phase II activity and receives orphan drug status for tesetaxel
Read More
Kythera reports positive phase II results for ATX-101 in submental fat reduction
Read More
YM's nimotuzumab to be evaluated in phase II and III trials for cancer
Read More
Phase III trial starts for GammaGard Liquid in primary immunodeficiency
Read More
CHMP recommends orphan drug status for ARG-201 in systemic sclerosis
Read More
Cubist submits two INDs targeting serious infections
Read More
Cytochroma commences phase I CTAP-201 injection in chronic kidney disease
Read More
Cylene initiates phase I trial with CK2 protein kinase inhibitor, CX-4945
Read More
ChemoCentryx divulges new chemokine CCR1 receptor antagonists for immune disorders
Read More
BioMarin and La Jolla enter worldwide agreement for Riquent
Read More
Novel DGAT-1 inhibitors discovered by Janssen researchers
Read More
GSK scientists describe new AMPA receptor agonists in recent patent
Read More
CureVac receives FDA IND approval for phase I/IIa mRNA vaccine trial
Read More
Novel ghrelin receptor ligands under development at GSK for treatment of obesity
Read More
Bayer Schering Pharma submits Visanne for registration in Europe for endometriosis
Read More
New antibacterial agents reported in recent Meiji Seika patent
Read More
Emergent BioSolutions ends activities to acquire Protein Sciences
Read More
UCB receives FDA complete response letter for Cimzia in RA
Read More